En contra: Microcarcinoma diferenciado de tiroides y carcinoma diferenciado de bajo riesgo: objeciones al tratamiento ablativo con radioyodo
Sánchez Franco, Franco.
Endocrinol. nutr. (Ed. impr.)
; 53(6): 399-404, jun. 2006. tab
Artículo en Es | IBECS (España) | ID: ibc-046315
Documentos relacionados
A systematic review of primary active surveillance management of low-risk papillary carcinoma.
Poorly differentiated thyroid carcinoma and poorly differentiated area in differentiated thyroid carcinoma: is there any difference?
High-grade salivary carcinomas: A current insight on diagnostic pathology and the key to clinical decision making.
Carcinoma-associated fibroblasts: orchestrating the composition of malignancy.
Can the follow-up of patients with papillary thyroid carcinoma of low and intermediate risk and excellent response to initial therapy be simplified using second-generation thyroglobulin assays?
Correlation between choroid plexus carcinoma and Li-Fraumeni syndrome: implications of TP53 mutations and management strategies-a case-based narrative review.
Cellular Senescence in the Treatment of Ovarian Cancer.
Hydropulsion as Palliative, Long-Term, Last-Resort Treatment of Nasal Carcinoma in a Dog and a Cat.
Clinicopathologic features of kinase fusion-related thyroid carcinomas: an integrative analysis with molecular characterization.
[Thyroid carcinomas - current therapeutic procedures].